RECCE PHARMACEUTICALS LTD — Major Shareholding Notification 2023

Sep 19, 2023

Form 603 Corporations Act 2001 Section 671B

Notice of Initial Substantial Holder

To: RECCE PHARMACEUTICALS LTD

ACN/ARSN:

1. Details of substantial holder (1)

Name: FIL Limited and the entities listed in Annexure A ("FIL") ACN/ARSN (if applicable)

The holder became a substantial holder on

18 September 2023

2. Details of voting power

The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in on the date the substantial holder became a substantial holder are as follows:

Class of Securities (4)	Number of securities	Person’s votes (5)	Voting power (6)
COMMON STOCK	15,144,466	15,144,466	7.69%

3. Details of relevant interests

The nature of the relevant interest the substantial holder or an associate had in the following voting securities on the date the substantial holder became a substantial holder are as follows:

Refer to Annexure A

4. Details of present registered holders

The persons registered as holders of the securities referred to in paragraph 3 above are as follows:

Refer to Annexure A

5. Consideration

The consideration paid for each relevant interest referred to in paragraph 3 above, and acquired in the four months prior to the day that the substantial holder became a substantial holder is as follows:

Date of Acquisition	Holder of	Consideration (9)	Class and
	Relevant Interest		Number of Securities
			COMMON STOCK
09/18/2023	FIL	0.4400 AUD	8,191,153

6. Associates

The reasons the persons named in paragraph 3 above are associates of the substantial holder are all follows:

Name and ACN/ARSN (if applicable) Nature of association

N/A

7. Addresses

The addresses of persons named in this form are as follows:

Refer to Annexure A

==> picture [115 x 23] intentionally omitted <==

Sign Here ____________________________________

Dated: 20 September 2023 Patrick Cheung Head of Regulatory Reporting, Asia Pacific Duly authorized under Powers of Attorney by and on behalf of FIL Limited

Annexure A

==> picture [513 x 82] intentionally omitted <==

----- Start of picture text ----- Investment Manager Address Custodian Nature of Relevant Sum of NumeratorInterest SharesFIL Investment Level 21, Two Pacific BROWN BROS HARRIMN LTD LUX (C) 10,445,312Management (Hong Place, 88 Queensway, CLEARSTREAM BANKING SA LUX (C) Investment Discretion 2,603,341Kong) Limited Admiralty, Hong Kong LANDESBANK / Voting Power2,095,813BADEN-WUERTTEMBERGGrand Total 15,144,466----- End of picture text -----